We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
Presence of (or history of) ovarian cysts or polycystic ovary syndrome is not a contraindication to IUC use.
As the Cu-IUD has no effect on the hypothalamic-pituitary-ovarian axis, no effect on BMD would be expected
Bleeding
Ensure potential Cu-IUD users are informed about possible bleeding pattern changes, to inform decision-making and improve satisfaction rates.
The Cu-IUD has been associated with an increase in menstrual blood loss and intermenstrual bleeding, secondary to increased release of prostaglandin and other vasoactive agents within the endometrium as part of an inflammatory response.
Bleeding may be heavier, longer or more painful than prior to Cu-IUD insertion and users may experience intermenstrual bleeding.
Increased menstrual bleeding will often decrease over time; however, intermenstrual bleeding is less likely to do so.
As with other LARC methods, increased bleeding is often cited as the most common reason for discontinuation of a Cu-IUD. However, continuation rates for Cu-IUDs are high, suggesting that in spite of this the method is often highly acceptable.
Other Side effects
For most users a Cu-IUD has either no impact or a positive impact on sexual experiences.
DGRefHelp - NHS Dumfries & Galloway